Seller record · bmimd.com

bmiMD

Recorded September 2026 · Standard v1.1

Fails 2 of 8 criteria. S2, prescription gating: The order path asks no medical question. Its quiz asks a weight-loss goal, a target amount and a plan, then states that the buyer is eligible and offers a checkout, and the home page places the medical questionnaire after the order. 1 more criterion also fails; see the table below.

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide beside sermorelin, NAD+, glutathione and metformin. It prints every price on its home page, names one filling pharmacy with a street address, and takes an order before it asks a medical question.

Operating entity Medccm Inc

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	bmimd.com
S2	Prescription gating	FAIL	bmimd.com/glp-1-quiz/
S3	Pharmacy identification	PASS	bmimd.com/terms-of-use/
S4	Compounding disclosure	PASS	bmimd.com/compounded-semaglutide/
S5	Analytical documentation	FAIL	bmimd.com
S6	Business address	PASS	bmimd.com/terms-of-use/
S7	Price disclosure	PASS	bmimd.com
S8	Enforcement status	PASS	fda.gov

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSBoard-certified physicians review the online medical questionnaire and hold the prescribing decision, stated in the ordering steps on the home page.Source: bmimd.com.

S2FAILThe order path asks no medical question. Its quiz asks a weight-loss goal, a target amount and a plan, then states that the buyer is eligible and offers a checkout, and the home page places the medical questionnaire after the order.Source: bmimd.com/glp-1-quiz/.

S3PASSPrecision Compounding Pharmacy is named as the fulfillment pharmacy with a street address in Bellmore, New York, and a telephone number.Source: bmimd.com/terms-of-use/.

S4PASSProduct pages state that compounded medications are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated for safety, efficacy or quality.Source: bmimd.com/compounded-semaglutide/.

S5FAILThe testing panel prints four results with no document behind any of them. Potency, sterility, pH and endotoxicity each read Passed beside the unfilled labels Date and Lab, and the two links in that block go to USP standards pages rather than to a certificate.Source: bmimd.com.

S6PASSThe terms print a New York street address with a suite number for contact and for dispute notices. Two further addresses appear in the same document for arbitration opt-outs, in Michigan and in Brooklyn.Source: bmimd.com/terms-of-use/.

S7PASSEvery treatment carries a monthly price on the home page before any intake, each shown as a reduction against a higher figure under a seasonal banner.Source: bmimd.com.

S8PASSNo FDA warning letter names this seller, and the control letter found in the same run proves the search worked. The screen covered the brand and the operating entity Medccm Inc across the full index.Source: fda.gov.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin injection, tablet and nasal spray, NAD+ injection and nasal spray, glutathione injection, metformin and MIC-B12.

Partner link. The site earns a commission on care started through it. Funding.

Visit bmiMD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.